P507 Efficacy of Infliximab after failure of subcutaneous anti-TNF agents in patients with moderate-to-severe ulcerative colitis

Autor:	A Christidou, Georgios Theocharis, Olga Giouleme, M Tzouvala, E. Archavlis, Christos Pontas, G Filippidis, Emmanouela Tsoukali, G Karampekos, Nikos Viazis, Gerassimos J. Mantzaris, Michail Galanopoulos
Rok vydání:	2019
Předmět:	Moderate to severe medicine.medical_specialty business.industry Gastroenterology General Medicine medicine.disease Ulcerative colitis Infliximab Internal medicine medicine Tumor necrosis factor alpha In patient business medicine.drug
Zdroj:	Journal of Crohn's and Colitis. 13:S366-S367
ISSN:	1876-4479 1873-9946
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::cdcd2498aacf0967bd789b2852a1f1be https://doi.org/10.1093/ecco-jcc/jjy222.631 Zobrazit plný text záznamu